Abstract Details

Title Motor Improvement in Early Parkinson Disease under Treatment with Safinamide a New Neuroprotectant. Results from a Parallel Double Blind Placebo Controlled Multinational Study

Topic

Presentation(s)

Poster/Presentation
Number 094

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Hadi Mohammad Khanli, MD (City of Hope National Cancer Center)	Dr. Mohammad Khanli has nothing to disclose.
David H. Margolin, MD, PhD (Genzyme Corporation)	Dr. Margolin has received personal compensation for serving as an employee of Cerevance, Inc. Dr. Margolin has received personal compensation in the range of $0-$499 for serving as a Consultant for Datacubed Health. Dr. Margolin has received stock or an ownership interest from Cerevance, Inc. Dr. Margolin has received stock or an ownership interest from Datacubed Health. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
	No disclosure on file
Madalina Chirieac, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
Xiaodong Luo	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file